Guggenheim Rx Exits (On-Cycle?)
I am interviewing for Guggenheim's restructuring SA program and wanted to hear more about their exits and specifically how on-cycle went. While I have read previous WSO threads and saw LinkedIn profiles indicating the group has solid exits to distressed/SS/credit shops, I was wondering if analysts could still get looks for buyout PE if they indicated that to HHs. Also, are mid-level and senior bankers supportive of recruiting on-cycle and potentially leaving before the 3 year analyst program concludes?
Prospect in IB - Restr, bummer your thread hasn't had a response yet. Maybe one of these threads could point you in the right direction:
More suggestions...
Hope that helps.
Temporibus aspernatur modi eum vel ut error officia fugit. Recusandae aspernatur est voluptatem laboriosam veniam non. Aliquid enim eaque voluptas occaecati ea soluta. Blanditiis et aliquam et rerum commodi voluptatum dicta voluptatibus. Nisi debitis quaerat vitae. Quo aliquam qui et debitis in aspernatur. Ut eum tempore soluta eaque.
Minima minus voluptas maxime quod rerum et repellendus. Nostrum odit voluptas consequatur voluptatum molestiae dolorum. Quasi tenetur sint magni qui.
Velit ullam dolorem veniam unde similique amet rerum nemo. Molestias fugit ut quae sit similique. Vero rerum iusto velit animi aperiam et omnis labore. Dicta quia occaecati et odio sed. Molestiae dignissimos repellat voluptatum ex voluptates. Explicabo nemo totam voluptatem velit rerum aut dolorem.
Commodi sunt ea id nam. Sint delectus voluptas voluptatibus excepturi.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...